IFG Advisory’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-392
Closed -$201K 511
2022
Q4
$201K Buy
+392
New +$199K 0.02% 466
2022
Q2
Sell
-1,186
Closed -$582K 481
2022
Q1
$582K Buy
1,186
+29
+3% +$13.3K 0.06% 281
2021
Q4
$536K Sell
1,157
-49
-4% -$20.6K 0.05% 286
2021
Q3
$449K Sell
1,206
-27
-2% -$10.3K 0.05% 316
2021
Q2
$470K Sell
1,233
-1,438
-54% -$550K 0.05% 301
2021
Q1
$958K Buy
2,671
+200
+8% +$64.3K 0.12% 195
2020
Q4
$793K Buy
2,471
+31
+1% +$9.51K 0.11% 200
2020
Q3
$655K Buy
2,440
+543
+29% +$146K 0.11% 203
2020
Q2
$498K Buy
1,897
+34
+2% +$9.07K 0.09% 220
2020
Q1
$422K Buy
1,863
+160
+9% +$43.6K 0.09% 216
2019
Q4
$514K Buy
1,703
+102
+6% +$28.1K 0.09% 231
2019
Q3
$384K Buy
1,601
+704
+78% +$193K 0.07% 265
2019
Q2
$253K Sell
897
-455
-34% -$124K 0.04% 298
2019
Q1
$387K Sell
1,352
-238
-15% -$68.8K 0.07% 227
2018
Q4
$417K Sell
1,590
-370
-19% -$102K 0.1% 198
2018
Q3
$537K Buy
1,960
+135
+7% +$35K 0.1% 194
2018
Q2
$434K Sell
1,825
-3
-0.2% -$695 0.09% 215
2018
Q1
$401K Buy
1,828
+46
+3% +$10.8K 0.09% 218
2017
Q4
$400K Buy
+1,782
New +$380K 0.09% 209

Other funds holding ELV

IFG Advisory's ELV Position: Q1 2023 in Review

IFG Advisory sold out of Elevance Health (ELV) in Q1 2023, closing a stake of 392 shares — an estimated $201K sold.

IFG Advisory first reported a position in ELV in Q4 2017 and held it in 19 quarters. The position peaked at $958K in Q1 2021. 1,516 funds tracked by Wall St. Rank hold ELV as of Q1 2023.

  • IFG Advisory reported no remaining Elevance Health position as of Q1 2023 after selling out during the quarter.
  • IFG Advisory sold 392 Elevance Health shares in Q1 2023, an estimated $201K.
  • IFG Advisory first reported a position in Elevance Health in Q4 2017 and held it in 19 quarters.
  • IFG Advisory's Elevance Health position peaked at $958K in Q1 2021.
  • 1,516 funds tracked by Wall St. Rank held Elevance Health as of Q1 2023.

Based on IFG Advisory's 13F filing for Q1 2023, filed 26 Apr 2023.